(2541466), M. Q., (15010), P. M., (104852), Y. Z., (95017), H. J., (22686257), L. G., (8495742), G. L., . . . (8665254), J. G. (2025). Table 1_Immune checkpoint inhibitor therapy in advanced cancer: Clinical association of irAEs type, inflammatory markers and efficacy.docx.
Čikaški stil citiranja (17. izdanje)(2541466), Mengying Qian, Ping Ma (15010), Yu Zhao (104852), Hao Jiang (95017), LiYang Gao (22686257), Gaoyang Lin (8495742), Difan Duan (22686260), i Jinmin Guo (8665254). Table 1_Immune Checkpoint Inhibitor Therapy in Advanced Cancer: Clinical Association of IrAEs Type, Inflammatory Markers and Efficacy.docx. 2025.
MLA način citiranja (9. izdanje)(2541466), Mengying Qian, et al. Table 1_Immune Checkpoint Inhibitor Therapy in Advanced Cancer: Clinical Association of IrAEs Type, Inflammatory Markers and Efficacy.docx. 2025.